Safety and efficacy of low-dose intravenous immune globulin (IVIG) treatment for infants and children with immune thrombocytopenic purpura

Journal of Pediatric Hematology/Oncology

Volumn 19, Issue 3, 1997, Pages 197-201

  Warrier, Indira ^c   Bussel, James B ^m   Valdez, Leticia ^d   Barbosa, Jerry ⁱ   Beardsley, Diana S ^m   Grossi, Mauro ^a   Berkow, Roger ^b   Rado, Thomas ^b   Siegel, Robert ^e   Weinstein, Ralph ^f   Henry, David ^g   Wallach, Sabina ^h   Greenberg, Bernard ^j   Weinstein, Steven ^j   Hoots, W Keith ^k   Zeigler, Zella ^l  

^a Buffalo Children's Hospital   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^d CHILDREN S MEDICAL CENTER   (United States)

^e GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^f LEGACY GOOD SAMARITAN HOSPITAL   (United States)

^g GRADUATE HOSPITAL   (United States)

^h NEW ENGLAND BAPTIST HOSPITAL   (United States)

ⁱ WEILL CORNELL MEDICAL CENTER   (United States)

^j UNIVERSITY OF CONNECTICUT   (United States)

^k UNIVERSITY OF TEXAS   (United States)

^l WESTERN PENNSYLVANIA HOSPITAL   (United States)

^m NONE

more..

Author keywords

Immune thrombocytopenic purpura in childhood; Intravenous immune globulin

Indexed keywords

IMMUNOGLOBULIN;

ARTICLE; ASEPTIC MENINGITIS; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG HYPERSENSITIVITY; FEVER; HEADACHE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE COUNT; VOMITING;

CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; MALE; PROSPECTIVE STUDIES; PURPURA, THROMBOCYTOPENIC; TREATMENT OUTCOME;

EID: 8544234240     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-199705000-00004     Document Type: Article

References (16)

1. Dubansky AS, Oski FA. Controversies in the management of acute idiopathic thrombocytopenic purpura: a survey of specialists. J Pediatr 1986;77(1):49-52.
2. Imbach P, Muller B, Imholz B, et al. Intravenous immunoglobulin therapy in immune thrombocytopenic purpura (ITP) and other immune related haemorrhagic disorders in childhood. In: Morall A, Nydegger UE, eds. Clinical use of intravenous immunoglobulins. Proceedings of a conference at Interlaken, September 15-18, 1985. Orlando, FL, Academic Press, Harcourt-Brace-Jovanovich, 1986: 177-87.
3. Blanchette VS. High dose intravenous gammaglobulin therapy in childhood immune thrombocytopenic purpura. In: Morall A, Nydegger UE, eds. Clinical use of intravenous immunoglobulins. Proceedings of a conference at Interlaken, September 15-18, 1985. Orlando, FL, Academic Press, Harcourt-Brace-Jovanovich, 1986: 223-31.
4. Bussel JB, Schulman I, Hilgartner M, et al. Intravenous use of gamma globulin in the treatment of chronic immune thrombocytopenic purpura as a means to defer splenectomy. J Pediatr 1983;103:651-3.
5. Bussel JB, Kimberly RP, Inman RD, et al. Intravenous gamma globulin treatment of chronic idiopathic thrombocytopenic purpura. Blood 1983;62:480-6.
6. Mori PG, Mancuso GT, DelPrincipe D, et al. Chronic idiopathic thrombocytopenia treated with immunoglobulin. Arch Dis Child 1983;58:851-5.
7. Newland AC, Traleaven JG, Minchinton RM, et al. High-dose intravenous IgG in adults with autoimmune thrombocytopenia. Lancet 1983;1:84-7.
8. Carroll RR, Noyes WD, Rosse WF, et al. Intravenous immunoglobulin administration in the treatment of severe chronic immune thrombocytopenic purpura. Am J Med 1984;76 (Suppl 3A):181-6.
9. Knapp MJ, Colburn PA. Clinical uses of intravenous immune globulin. Clinical Pharmacy 1990;9 (Drug Reviews):509-29.
10. Bussel JB, Goldman A, Imbach P, et al. Treatment of acute idiopathic thrombocytopenia of childhood with intravenous infusions of gamma globulin. J Pediatr 1985;106:886-90.
11. Imbach P, Wagner HP, Berchtold W. Intravenous immunoglobulin versus oral corticosteroids in immune thrombocytopenic purpura in childhood. Lancet 1985;2:464-8.
12. Blanchette V, Imbach P, Andrew M, et al. Randomized trial of intravenous immunoglobulin G, intravenous anti-D and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 1994;344:703-7.
13. Blanchette VS, Luke B, Andrew M, et al. A prospective randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. J Pediatr 1993;123:989-95.
14. Duhem C, Dicato MA, Ries F. Side effects of intravenous immune globulins. Clin Exper Immunol 1994:97 (Suppl 1):79-83.
15. VanDaele MC, Wijndable L, Hunninck K, et al. Intravenous immune globulin and acute aseptic meningitis. N Engl J Med 1990 (Correspondence);323:614-5.
16. Kato E, Shindo S, Eto Y, et al. Administration of immune globulin associated with aseptic meningitis. JAMA 1988 (Letters);259: 3269-71.